Qualitative thrombelastographic detection of tissue factor in human plasma

Anesthesia and Analgesia

Volumn 104, Issue 1, 2007, Pages 59-64

  Nielsen, Vance G ^a   Audu, Paul ^b   Cankovic, Lana ^a   Lyerly III, Ralph T ^a   Steenwyk, Brad L ^a   Armstead, Valerie ^b   Powell, Garry ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; THROMBOPLASTIN;

ARTICLE; BLOOD ANALYSIS; BLOOD CLOTTING TIME; CONCENTRATION RESPONSE; DILUTION; HUMAN; INCUBATION TIME; MEDICAL INSTRUMENTATION; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOELASTOGRAPHY; THROMBOGENESIS; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 12 DEFICIENCY; DRUG EFFECT; HEMOSTASIS; METHODOLOGY; REFERENCE VALUE;

BLOOD COAGULATION; FACTOR XII DEFICIENCY; HEMOSTASIS; HUMANS; REFERENCE VALUES; THROMBELASTOGRAPHY; THROMBOPLASTIN;

EID: 33847608690     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000248223.05152.a1     Document Type: Article

References (19)

1. He M, Wen Z, He X, et al. Observation on tissue factor pathway and some other coagulation parameters during the onset of acute cerebrocardiac thrombotic diseases. Thromb Res 2002;107:223-8.
2. Koyama T, Nishida K, Ohdama S, et al. Determination of plasma tissue factor antigen and its clinical significance. Br J Haematol 1994;87:343-7.
3. Blann AD, Amiral J, McCollum CN, Lip GYH. Differences in free and total tissue factor pathway inhibitor and tissue factor in peripheral artery disease compared to healthy controls. Atherosclerosis 2000;152:29-34.
4. Falciani M, Gori AM, Fedi S, et al. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients. Thromb Haemost 1998;79:495-9.
5. Asakura H, Kamikubo Y, Goto A, et al. Role of tissue factor in disseminated intravascular coagulation. Thromb Res 1995;80:217-24.
6. Ueda C, Hirohata Y, Kihara Y, et al. Pancreatic cancer complicated by disseminated intravascular coagulation associated with production of tissue factor. J Gastroenterol 2001;36:848-50.
7. Kamikura Y, Wada H, Nobori T, et al. Elevated levels of leukocyte tissue factor mRNA in patients with venous thromboembolism. Thromb Res 2005;116:307-12.
8. Han LY, Landen Jr CN, Kamat AA, et al. Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma. J Clin Oncol 2006;24:755-61.
9. Caine GJ, Harris AL, Christodoulos K, et al. Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer. Cancer Lett 2005;219:163-7.
10. Hathaway WE, Hays T. Hypercoagulability in childhood cancer. J Pediatr Surg 1975;10:893-9.
11. Haid M. Thromboelastographic distinction of malignant from benign breast masses: a preliminary report. South Med J 1977;70:774-6.
12. Francic JL, Francic DA, Gunathilagan GJ. Assessment of hypercoagulability in patients with cancer using the Sonoclot analyzer and thrombelastography. Thromb Res 1994;74:335-46.
13. Nielsen VG, Steenwyk BL, Gurley WQ, et al. Argatroban, bivalirudin and lepirudin do not decrease clot propagation and strength as effectively as heparin activated antithrombin in vitro. J Heart Lung Transplant 2006;25:653-63.
14. Holmes MB, Schneider DJ, Hayes MG, et al. Novel, bedside, tissue factor-dependent clotting assay permits improved assessment of combination antithrombotic and antiplatelet therapy. Circulation 2000;102:2051-7.
15. Butenas S, Cawthern KM, van't Veer C, et al. Antiplatelet agents in tissue factor-induced blood coagulation. Blood 2001;97:2314-22.
16. Liebman HA, Feinstein DI. Thrombosis in patients with paroxysmal noctural hemoglobinuria is associated with markedly elevated plasma levels of leukocyte-derived tissue factor. Thromb Res 2003;111:235-8.
17. Santucci RA, Erlich J, Labriola J, et al. Measurement of tissue factor activity in whole blood. Thromb Haemost 2000;83:445-54.
18. Marsik C, Quehenberger P, Mackman N, et al. Validation of a novel tissue factor assay in experimental human endotoxemia. Thromb Res 2003;111:311-15.
19. Gladner JA, Nossal R. Effects of crosslinking on the rigidity and proteolytic susceptibility of human fibrin clots. Thromb Res 1983;30:273-88.